The present invention features compounds of formula (I) or pharmaceutically acceptable salts, solvates thereof, and compounds of formula (I) for use in inhibiting the metabolizing activities of CYP enzymes. The present invention also features compounds of formula (I) for use in improving the pharmacokinetics of drugs that are metabolized by CYP enzymes.